Catherine Do

This profile gathers the share dealings of Catherine Do across 2 companies, led by Drugs Made In America Acquisition Corp. and Drugs Made In America Acquisition II Corp. Over a trading history stretching from 29 January 2025 to 26 September 2025, the count stands at 2 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 17 October 2025, reports a transaction in Drugs Made In America Acquisition II Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.